LONDON (Reuters) - Shares in AstraZeneca fell 2.4 percent in early trade on Tuesday after U.S. drugmaker Pfizer said it would not make a formal bid to acquire its smaller British rival.
via elEconomista Mercados http://ift.tt/1jWPc1V http://ift.tt/eA8V8J
via elEconomista Mercados http://ift.tt/1jWPc1V http://ift.tt/eA8V8J
No hay comentarios:
Publicar un comentario